Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Summary of variables with regard to mortalityOverallMortality p No (n = 616)Yes (n = 136)Age75.33 ± 6.7974.21 ± 6.3480.35 ± 6.50< 0.001 †Sex Male228 (30.32%)176 (28.57%)52 (38.24%)0.026 # Female524 (69.68%)440 (71.43%)84 (61.76%)Weight, kg70.12 ± 13.5371.18 ± 13.5165.33 ± 12.60< 0.001 †Height, cm157.41 ± 9.25157.59 ± 9.07156.61 ± 10.020.264†Body mass index, kg/m228.35 ± 5.2628.71 ± 5.2426.72 ± 5.04< 0.001 †Obesity254 (33.78%)220 (35.71%)34 (25.00%)0.017 #Waist circumference, cm99.17 ± 12.2999.25 ± 12.2098.80 ± 12.740.701†Hip circumference, cm106.42 ± 10.24107.01 ± 10.08103.66 ± 10.580.001 †Waist to hip ratio0.93 ± 0.090.93 ± 0.090.95 ± 0.090.003 †High578 (79.61%)474 (79.26%)104 (81.25%)0.700#Upper arm circumference, cm28.88 ± 4.0329.32 ± 3.9526.87 ± 3.77< 0.001 †Calf circumference, cm36.17 ± 4.4836.56 ± 4.4034.37 ± 4.43< 0.001 †A body shape index0.086 ± 0.0070.085 ± 0.0070.089 ± 0.007< 0.001 †Fat mass, kg31.19 ± 9.8932.12 ± 9.3326.29 ± 11.30< 0.001 †Free fat mass, kg45.60 ± 8.2245.90 ± 8.2144.41 ± 8.220.096†GDS score3 (1 to 7)3 (1 to 6)4 (1 to 8)0.009 ‡Hand grip strength, kg21.45 ± 8.3121.95 ± 8.3419.15 ± 7.78< 0.001 †Gait speed, m/s0.97 ± 0.391.01 ± 0.370.78 ± 0.38< 0.001 †Sarcopenia275 (36.57%)198 (32.14%)77 (56.62%)< 0.001 #Sarcopenic obese80 (10.64%)61 (9.90%)19 (13.97%)0.215#Hypertension546 (72.61%)447 (72.56%)99 (72.79%)0.957#Hyperlipidemia147 (19.55%)120 (19.48%)27 (19.85%)0.921#Diabetes mellitus259 (34.44%)213 (34.58%)46 (33.82%)0.867#Atrial fibrillation29 (3.86%)18 (2.92%)11 (8.09%)0.010 #Ischemic heart disease123 (16.36%)97 (15.75%)26 (19.12%)0.336#Heart failure29 (3.86%)17 (2.76%)12 (8.82%)0.002 #Hypothyroidism107 (14.23%)90 (14.61%)17 (12.50%)0.616#Parkinson’s disease24 (3.19%)15 (2.44%)9 (6.62%)0.026 §Dementia35 (4.65%)17 (2.76%)18 (13.24%)< 0.001 #Depression165 (21.94%)141 (22.89%)24 (17.65%)0.221#Cerebrovascular disease28 (3.72%)22 (3.57%)6 (4.41%)0.827#Lung disease76 (10.11%)55 (8.93%)21 (15.44%)0.034 #Number of medication use5 (2 to 7)5 (2 to 7)5 (3 to 8)0.014 ‡Creatinine, mg/dL0.83 (0.74 to 1.01)0.82 (0.73 to 0.99)0.90 (0.77 to 1.14)0.001 ‡Calcium, mg/dL9.6 (9.1 to 10.0)9.7 (9.2 to 10)9.5 (9.0 to 10.0)0.021 ‡Phosphor, mg/dL3.5 (3.0 to 3.9)3.5 (3.0 to 3.9)3.3 (3.0 to 3.95)0.245‡Magnesium, mg/dL1.90 (1.75 to 2.04)1.90 (1.75 to 2.03)1.87 (1.75 to 2.07)0.985‡Albumin, g/dL4.3 (4.1 to 4.5)4.3 (4.1 to 4.5)4.1 (3.8 to 4.3)< 0.001 ‡PTH, pg/mL60.8 (43.3 to 82.4)60.7 (44.2 to 82.4)61.05 (39.38 to 82.36)0.466‡Vitamin D, ng/mL24.3 (16.2 to 32.0)24.2 (16.4 to 31.9)24.9 (13.9 to 35.0)0.948‡Lymphocyte (x103)1.98 (1.61 to 2.46)2.00 (1.63 to 2.45)1.84 (1.50 to 2.49)0.047 ‡Total cholesterol, mg/dL208.26 ± 48.78212.41 ± 47.91189.27 ± 48.40< 0.001 †DEXA Vertebra t score−2.32 ± 1.18−2.41 ± 1.09−2.13 ± 1.310.137†DEXA Femoral t score−2.42 ± 0.74−2.38 ± 0.73−2.51 ± 0.770.243†MNA Short form score12 (11 to 14)13 (11 to 14)11 (9 to 13)< 0.001 ‡MNA Long form score25 (22 to 27)25.5 (22.5 to 27.25)23 (17.5 to 26)< 0.001 ‡CONUT score0 (0 to 1)0 (0 to 1)1 (0 to 2)< 0.001 ‡GNRI score105.73 (101.26 to 108.71)105.73 (102.75 to 108.71)102.36 (97.00 to 105.58)< 0.001 ‡PNI score53.1 (49.9 to 55.9)53.33 (50.7 to 56.1)50.05 (46.9 to 54.5)< 0.001 ‡Follow-up time, months55 (50 to 58)57 (53 to 58)33.5 (19 to 46)< 0.001 ‡Fracture history150 (19.94%)110 (17.86%)40 (29.41%)0.002 #Descriptive statistics were presented using mean ± standard deviation for normally distributed continuous variables, median (25th percentile − 75th percentile) for non-normally distributed continuous variables, and frequency (percentage) for categorical variablesCONUT Controlling nutritional status, DEXA Dual x-ray absorptiometry, GDS Geriatric depression scale, GNRI Geriatric nutritional risk index, MNA Mini nutritional assessment, PNI Prognostic nutritional index, PTH Parathormone† Student’s t test, ‡ Mann Whitney U test, # Chi-square test, § Fisher’s exact test
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Impact of nutritional status on mortality in geriatric patients with osteoporosis: a retrospective cohort study
Source: Article title.
Patients with conditions that could distort anthropometric parameters, such as decompensated heart failure with unstable hemodynamics or marked lower limb edema, were also excluded, as all participants were ambulatory outpatients.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Impact of nutritional status on mortality in geriatric patients with osteoporosis: a retrospective cohort study
Cohort study · BMC Geriatrics · 2025
Original publication title
Impact of nutritional status on mortality in geriatric patients with osteoporosis: a retrospective cohort study
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
This study investigated the relationship between mortality and numerous characteristics in geriatric patients with osteoporosis, including nutritional, clinical, anthropometric, and biochemical factors.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective cohort comprised geriatric patients diagnosed with osteoporosis between January 2016 and December 2019. Demographics, anthropometrics, comorbidities, laboratory results, bone mineral density (DEXA) analyses, fracture history, and mortality data were obtained. In addition, nutritional status, hand grip strength, and gait speed were measured. The Geriatric Depression Scale (GDS) was applied and nutritional status was assessed using multiple tools: Mini Nutritional Assessment (MNA) Short and Long Forms, Controlling Nutritional Status (CONUT), Geriatric Nutritional Risk Index (GNRI), and Prognostic Nutritional Index (PNI).
Source: MethodsAbstract: Results
Among the 752 patients (mean age 75.3 ± 6.8 years, 69.7% female), the mortality rate was 18.1% during a median follow-up of 55 months. Nutritional assessments significantly predicted both fracture occurrence and mortality. Optimal cut-offs for predicting mortality were: MNA Short Form ≤ 11, MNA Long Form ≤ 24, CONUT > 1.5, GNRI ≤ 105.5, and PNI ≤ 49.9. Independent predictors of mortality included increasing age (p < 0.001), male sex (p = 0.005), higher body shape index (p = 0.006), slower gait speed (p = 0.001), MNA Long Form score ≤ 24 (p = 0.002), and PNI score ≤ 49.9 (p < 0.001).
Source: ResultsAbstract: Conclusion
Malnutrition is strongly associated with higher mortality risk in older osteoporosis patients. Early identification of malnutrition is critical to administering appropriate interventions, and our results show that malnutrition deserves greater attention to understand its broader impacts on outcomes in geriatric patients, particularly those with osteoporosis.
Source: ConclusionAuthors’ abstract
Background
This study investigated the relationship between mortality and numerous characteristics in geriatric patients with osteoporosis, including nutritional, clinical, anthropometric, and biochemical factors.
Methods
This retrospective cohort comprised geriatric patients diagnosed with osteoporosis between January 2016 and December 2019. Demographics, anthropometrics, comorbidities, laboratory results, bone mineral density (DEXA) analyses, fracture history, and mortality data were obtained. In addition, nutritional status, hand grip strength, and gait speed were measured. The Geriatric Depression Scale (GDS) was applied and nutritional status was assessed using multiple tools: Mini Nutritional Assessment (MNA) Short and Long Forms, Controlling Nutritional Status (CONUT), Geriatric Nutritional Risk Index (GNRI), and Prognostic Nutritional Index (PNI).
Results
Among the 752 patients (mean age 75.3 ± 6.8 years, 69.7% female), the mortality rate was 18.1% during a median follow-up of 55 months. Nutritional assessments significantly predicted both fracture occurrence and mortality. Optimal cut-offs for predicting mortality were: MNA Short Form ≤ 11, MNA Long Form ≤ 24, CONUT > 1.5, GNRI ≤ 105.5, and PNI ≤ 49.9. Independent predictors of mortality included increasing age (p < 0.001), male sex (p = 0.005), higher body shape index (p = 0.006), slower gait speed (p = 0.001), MNA Long Form score ≤ 24 (p = 0.002), and PNI score ≤ 49.9 (p < 0.001).
Conclusion
Malnutrition is strongly associated with higher mortality risk in older osteoporosis patients. Early identification of malnutrition is critical to administering appropriate interventions, and our results show that malnutrition deserves greater attention to understand its broader impacts on outcomes in geriatric patients, particularly those with osteoporosis.
Publication and source details
Original title: Impact of nutritional status on mortality in geriatric patients with osteoporosis: a retrospective cohort study
Suna Avci; Filiz Demirdag; Zehra Kara; Pelin Degirmenci; Selcan Yenigun; Seyda Bilgin; Hasan Yuksel; Ali Kimiaei; Alper Doventas
BMC Geriatrics · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:38:12.604278+00:00
DOI: 10.1186/s12877-025-06601-5 · PMC12629002